Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID: Raltegravir switch for platelet reactivity in HIV
NCT02383355Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Radboud University Medical Center. Started Mar 2015; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02383355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02383355.